1.    Bernloehr, C., S. Bossow, G. Ungerechts, S. Armeanu, W. J. Neubert, U. M. Lauer, and M. Bitzer. 2004. Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res 99:193-7.

2.    Hurwitz, J. L., K. F. Soike, M. Y. Sangster, A. Portner, R. E. Sealy, D. H. Dawson, and C. Coleclough. 1997. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15:533-40.

3.    Kano, M., T. Matano, A. Kato, H. Nakamura, A. Takeda, Y. Suzaki, Y. Ami, K. Terao, and Y. Nagai. 2002. Primary replication of a recombinant Sendai virus vector in macaques. J Gen Virol 83:1377-86.

4.    Leyrer, S., W. J. Neubert, and R. Sedlmeier. 1998. Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods 75:47-58.

5.   Moriya, C., S. Horiba, M. Inoue, A. Iida, H. Hara, T. Shu, M. Hasegawa, and T. Matano. 2008. Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques. Biochem Biophys Res Commun 371:850-4.

6.      Skiadopoulos, M. H., S. R. Surman, J. M. Riggs, W. R. Elkins, M. St Claire, M. Nishio, D. Garcin, D. Kolakofsky, P. L. Collins, and B. R. Murphy. 2002. Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees. Virology 297:153-60.

7.      Slobod, K. S., J. L. Shenep, J. Luján-Zilbermann, K. Allison, B. Brown, R. A. Scroggs, A. Portner, C. Coleclough and J. Hurwitz. 2004. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 22: 318286.

8.   Takimoto, T., J. L. Hurwitz, C. Coleclough, C. Prouser, S. Krishnamurthy, X. Zhan, K. Boyd, R. A. Scroggs, B. Brown, Y. Nagai, A. Portner, and K. S. Slobod. 2004. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. J Virol 78:6043-7.

9.   Takimoto, T., J. L. Hurwitz, X. Zhan, S. Krishnamurthy, C. Prouser, B. Brown, C. Coleclough, K. Boyd, R. A. Scroggs, A. Portner, and K. S. Slobod. 2005. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunol 18:255-66.

10. Voges, B., S. Vallbracht, G. Zimmer, S. Bossow, W. J. Neubert, K. Richter, E. Hobeika, G. Herrler, and S. Ehl. 2007. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies. Cell Immunol 247:85-94.

11. Wiegand, M. A., S. Bossow, S. Schlecht, and W. J. Neubert. 2007. De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol 81:13835-44.

12. Zhan, X., J. L. Hurwitz, S. Krishnamurthy, T. Takimoto, K. Boyd, R. A. Scroggs, S. Surman, A. Portner, and K. S. Slobod. 2007. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine 25:8782-93.

13. Zhan, X., K. S. Slobod, S. Krishnamurthy, L. E. Luque, T. Takimoto, B. Jones, S. Surman, C. J. Russell, A. Portner, and J. L. Hurwitz. 2008. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 26:3480-8.

14. Zimmer, G., S. Bossow, L. Kolesnikova, M. Hinz, W. J. Neubert, and G. Herrler. 2005. A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus. J Virol 79:10467-77.